These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 3009618)

  • 21. Effects of low concentrations of arachidonic acid derived mediators on the membrane potential and respiratory burst responses of human neutrophils as assessed by flow cytometry.
    Fletcher MP; Halpern GM
    Fundam Clin Pharmacol; 1990; 4(1):65-77. PubMed ID: 2160416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressed leukotriene B4 chemotactic response of neutrophils from localized juvenile periodontitis patients.
    Offenbacher S; Scott SS; Odle BM; Wilson-Burrows C; Van Dyke TE
    J Periodontol; 1987 Sep; 58(9):602-6. PubMed ID: 2821216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide.
    Petersen M; Steadman R; Hallett MB; Matthews N; Williams JD
    Immunology; 1990 May; 70(1):75-81. PubMed ID: 2162325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
    Schleimer RP; Freeland HS; Peters SP; Brown KE; Derse CP
    J Pharmacol Exp Ther; 1989 Aug; 250(2):598-605. PubMed ID: 2547940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative effect of a protein kinase C inhibitor (H-7) on human polymorphonuclear neutrophil locomotion.
    Gaudry M; Perianin A; Marquetty C; Hakim J
    Immunology; 1988 Apr; 63(4):715-9. PubMed ID: 2835313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
    Grimminger F; Sibelius U; Aktories K; Suttorp N; Seeger W
    Mol Pharmacol; 1991 Oct; 40(4):563-71. PubMed ID: 1656192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
    Bauldry SA; McCall CE; Cousart SL; Bass DA
    J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclical binding, processing, and functional interactions of neutrophils with leukotriene B4.
    O'Flaherty JT; Redman JF; Jacobson DP
    J Cell Physiol; 1990 Feb; 142(2):299-308. PubMed ID: 2154503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the uptake, binding and metabolism of leukotriene B4 by human neutrophils.
    Brom J; König W
    Immunology; 1989 Dec; 68(4):479-85. PubMed ID: 2558070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
    Lawrence RH; Sorrelli TC
    Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
    Stewart AG; Harris T; De Nichilo M; Lopez AF
    Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moderate zinc deficiency in rhesus monkeys. An intrinsic defect of neutrophil chemotaxis corrected by zinc repletion.
    Vruwink KG; Fletcher MP; Keen CL; Golub MS; Hendrickx AG; Gershwin ME
    J Immunol; 1991 Jan; 146(1):244-9. PubMed ID: 1984446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of ibuprofen and diclofenac on the chemotaxis and adenosine triphosphate level of polymorphonuclear cells in vitro.
    Partsch G; Schwarzer C; Eberl R
    J Rheumatol; 1990 May; 17(5):583-8. PubMed ID: 2162960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mepacrine inhibits fMLP-induced activation of human neutrophil granulocytes, leukotriene B4 formation, and fMLP binding.
    Földes-Filep E; Filep JG
    J Leukoc Biol; 1992 Nov; 52(5):545-50. PubMed ID: 1331280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
    Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL
    Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transduction in human alveolar macrophages: diminished chemotactic response to FMLP correlates with a diminished density of Gi proteins and FMLP receptors.
    Beaty CD; Martin TR; Wilson CB
    Am J Respir Cell Mol Biol; 1991 Jul; 5(1):87-92. PubMed ID: 1908689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier.
    Casale TB; Abbas MK; Carolan EJ
    Am J Respir Cell Mol Biol; 1992 Jul; 7(1):112-7. PubMed ID: 1320901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
    McEwen BJ; Wilcock BP; Eyre P
    Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.
    Harvath L; Balke JA; Christiansen NP; Russell AA; Skubitz KM
    J Immunol; 1991 Feb; 146(3):949-57. PubMed ID: 1671052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.